Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lauritsen

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
BMC Musculoskeletal Disorders|May 17, 2019
Decision-making, therapy, and outcome in lateral compression fractures of the pelvis - analysis of a single center treatmentJ Zwingmann, H Eberbach, P C Strohm, et al.
Acta Psychiatrica Scandinavica|October 1, 1981
Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearanceB J Lauritsen, E T Mellerup, P Plenge, et al.
European Journal of Neurology|July 16, 2020
Moyamoya disease in a European setting: a Danish population-based studyP Birkeland, V Tharmabalan, J Lauritsen, et al.
The Journal of Biological Chemistry|May 1, 2001
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cellsH J List, K J Lauritsen, R Reiter, et al.
Journal of Psychoactive Drugs|November 24, 2015
Self-Medication of Somatic and Psychiatric Conditions Using Botanical MarijuanaLawrence A Osborn, Kirstin J Lauritsen, Nicole Cross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Renal impairment and late toxicity in germ-cell cancer survivorsJ Lauritsen, M S Mortensen, M G G Kier, et al.
Human Reproduction (Oxford, England)|July 5, 2021
Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapyL Priskorn, M Kreiberg, M Bandak, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivorsM Bandak, N Jørgensen, A Juul, et al.
Andrology|March 25, 2016
Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysisM Bandak, N Jørgensen, A Juul, et al.
Journal of Substance Abuse Treatment|September 24, 2018
Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatmentDavid H Morris, Alan K Davis, Kirstin J Lauritsen, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
BMC Musculoskeletal Disorders|May 17, 2019
Decision-making, therapy, and outcome in lateral compression fractures of the pelvis - analysis of a single center treatmentJ Zwingmann, H Eberbach, P C Strohm, et al.
Acta Psychiatrica Scandinavica|October 1, 1981
Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearanceB J Lauritsen, E T Mellerup, P Plenge, et al.
European Journal of Neurology|July 16, 2020
Moyamoya disease in a European setting: a Danish population-based studyP Birkeland, V Tharmabalan, J Lauritsen, et al.
The Journal of Biological Chemistry|May 1, 2001
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cellsH J List, K J Lauritsen, R Reiter, et al.
Journal of Psychoactive Drugs|November 24, 2015
Self-Medication of Somatic and Psychiatric Conditions Using Botanical MarijuanaLawrence A Osborn, Kirstin J Lauritsen, Nicole Cross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Renal impairment and late toxicity in germ-cell cancer survivorsJ Lauritsen, M S Mortensen, M G G Kier, et al.
Human Reproduction (Oxford, England)|July 5, 2021
Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapyL Priskorn, M Kreiberg, M Bandak, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivorsM Bandak, N Jørgensen, A Juul, et al.
Andrology|March 25, 2016
Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysisM Bandak, N Jørgensen, A Juul, et al.
Journal of Substance Abuse Treatment|September 24, 2018
Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatmentDavid H Morris, Alan K Davis, Kirstin J Lauritsen, et al.
Pageof 5